MedTrace Logo

Photodynamic Therapy for Oral Leukoplakia and Erythroleukoplakia

NCT00155337 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2012-12-21

No results posted yet for this study

Summary

Photodynamic therapy for oral leukoplakia and erythroleukoplakia

Conditions

  • Oral Leukoplakia

Interventions

PROCEDURE

photodynamic therapy

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Chun-Pin Chiang, DMSc · National Taiwan University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-08-31
Primary Completion
2007-12-31
Completion
2007-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00155337 on ClinicalTrials.gov